Replies to post #560 on Labwire Inc (LBWR)

[nsomniyak]

The oustanding share count (or, better, the fully diluted share count) should be used for all "valuation" metrics such as EPS. Float is relevant only to market issues like trading, spread, availability of shares, etc.

I'll buy your .20 projection, as it is based on outstanding shares. We can tweak the assumptions, or the values used, but that equation is valid in form.

Since the $1.75 figure was derived using float as share count, it is meaningless to me.

[shermann7]

That is one of the most coherent statements I have read. I am not a numbers cruncher. My belief is that the true value of this company is in the .50 cent range right now. The company is profitable. I am more interested in the fact that the industry for drug testing is growing so fast, and they have a lot of experience. I consider the company to be in a unique position. Becoming fully reporting would be a great step in the right direction. I am more of a buy and hold guy than a flipper, so this is good for me. I am also in BIGN which I consider to be in the same position. They have a recent problem due to the heavy rains in california and are in one of the counties which was declared a disaster area. The weather will clear up, and they will have a much higher PPS in another 6 months. Do you have any examples of a stock that is solid from a numbers standpoint. Maybe CTUM or something.

Shermann